期刊文献+

B19 VP2抗原真核表达载体的构建及免疫原性观察 被引量:3

Construction of eukaryotic expression vector pcDNA3/VP2 and its immunological effect
下载PDF
导出
摘要 目的:探讨以B19VP2基因为靶基因构建的真核表达载体作为基因疫苗的免疫原性。方法:用PCR方法以pGEM1B19为模板扩增出B19VP2目的基因;将其重组入真核表达载体pcDNA3;将重组子pcDNA3VP2及空质粒分别用脂质体包裹接种家兔;ELISA方法检测家兔血清中B19VP2抗体产生情况。结果:成功构建了真核表达载体pcDNA3-VP2;其作为基因疫苗接种家兔后可产生滴度较高,持续时间较长的抗体。结论:B19VP2基因可作为B19病毒基因疫苗构建的靶基因。 Aim: To explore the immunogenicity of pcDNA3/VP2 as gene vaccine. Methods: B19 VP2 gene was amplified using PCR. B19 VP2 was recombined with pcDNA3 to form pcDNA3/VP2. pcDNA3/VP2 packed with liposome was inoculated into laboratory rabbit. B19 VP2 antibody was detected in rabbit's serum using ELISA.Results: Eukaryotic vector pcDNA3/VP2 was successfully constructed, which had better immunogenicity as gene vaccine and could stimulate rabbit to generate higher titre antibody. Conclusion: B19 VP2 gene can be used as target gene of B19 virus gene vaccine.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2005年第3期377-379,共3页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省科技攻关基金资助项目01140512
关键词 人微小病毒B19 VP2抗原 免疫 家兔 human parvovirus B19 VP2 antigen immunogenicity rabbit
  • 相关文献

参考文献6

  • 1周旭,李益民,侯玲,白植生.轮状病毒DNA疫苗的制备及其抗体应答[J].中国生物制品学杂志,1999,12(2):72-74. 被引量:9
  • 2张以芳.核酸疫苗的构成及主要特点[J].上海畜牧兽医通讯,2000(2):11-11. 被引量:12
  • 3Young NS, Brown KE. Parvovirus B19. N Engl J Med,2004,350(6) :586.
  • 4Vafaie J, Schwartz RA. Parvovirus B19 infections. Int J Dermatol, 2004,43 ( 10 ) :747.
  • 5Kaufmann B, Simpson AA, Rossmann MG. The structure of human parvovirus B19. Proc Natl Acad Sci,2004,101 (32) :11 628.
  • 6Zaaijer HL, Koppelman MH, Farrington CP. Parvovirus B19 viraemia in Dutch blood donors. Epidemiol Infect,2004,132(6) :1 161.

二级参考文献8

  • 1金冬雁(译),分子克隆实验指南,1992年,24页
  • 2Israel M A,Chan H W and W P Rowe at al.Mclicular cloning of polyoma virus DNA in Eschericha coli phsmid vecter system.Scienee, 1979,203:883-887.
  • 3Chan H W,Israel M A and garon C F.Molicular cloning of polyoma virus DNA in Eschericha coli:Iambda phage vector system.Science,1979,203:888-892.
  • 4Will H,Catteneo R and H G Koch.Clone HBV DNA cause hepatitis in chimpanzees.Nature,1982,229:740-742.
  • 5Robison H L,Hunt L A and R G Webster.Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA.Nature,1994,12:957-960.
  • 6Haraharan M J.DNA immunization against heres simplex virus:ehanced efficacy using a Simdbis virus-based vector.J Virus,1998,72:950-958.
  • 7Montgomery D L.Heterologous and homologous protection against influenza A by DNA vaccination:optimiztion of DNA vector.DNA Cell Biol,1993,12:777-783.
  • 8李益民,周旭,白植生.用T-A载体克隆技术构建丙肝病毒C+E1区真核表达质粒pSVL-HCV/C+E1[J].微生物学免疫学进展,1997,25(4):25-27. 被引量:3

共引文献19

同被引文献29

  • 1谢广中.流行性乙型脑炎疫苗的不良反应及其防范[J].上海预防医学,2006,18(3):113-115. 被引量:9
  • 2钱新宏,焦富勇.细小病毒B_(19)与儿童疾病[J].中华儿科杂志,1997,35(2):107-109. 被引量:25
  • 3Stanley AP, Walter AO. Vaccines [M]. Ed3. Philadelphia: Saunder Company, 1999.
  • 4庄辉.病毒性肝炎的流行病学[A].全国病毒性肝炎防治研讨会论文集[C].杭州,2004.
  • 5Van Darnme P, Van Herck K. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine [J] . Expert Rev Vaccines, 2004,3 : 249:267.
  • 6Young NS, Brown KE. Parvovirus B19. N Engl J Med,2004,350 ( 6 ) :586.
  • 7Vafaie J, Schwartz RA. Parvovirus B19 infections. Int J Dermatol,2004,43 ( 10 ) :747.
  • 8Kaikkonen L, Lankinen H, Harjunpaa I, et al. Acute-phasespecific heptapeptide epitope for diagnosis of parvovirus B19 infection. J Clin Microbiol, 1999,37 (12) .3 952.
  • 9Zerbini M, Gallinella G, Cricca M,et al. Diagnostic procedures in B19 infection. Pathol Biol,2002,50(5) :332.
  • 10Pereira RF, Paula wrq, Cubel Rde C, et al. Anti-VP1 and anti-VP2 antibodies detected by immunofluorescence assays in patients with acute human parvovirus B19 infection. Mem Inst Oswaldo Cruz ,2001,96 (4) :507.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部